Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study

Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study

IntroductionClinical remission as a multicomponent treatment goal in severe asthma is being explored in clinical practice. This post hoc analysis used data from the REDES study to assess the proportion of patients with severe eosinophilic asthma achieving our multicomponent definitions of clinical r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ian Pavord, Frances Gardiner, Liam G. Heaney, Christian Domingo, Robert G. Price, Alison Pullan, John Oppenheimer, Guy Brusselle, Hiroyuki Nagase, Geoffrey Chupp, Emilio Pizzichini, David Bañas-Conejero, Peter Howarth
Formato: Artículo
Lenguaje:English
Publicado: Frontiers Media S.A. 2023-04-01
Colección:Frontiers in Immunology
Materias:
severe asthma
remission
clinical outcomes
real-world
eosinophil biology
mepolizumab
Acceso en línea:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1150162/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1150162/full

Ejemplares similares